Sfoglia per Autore
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology
2017-01-01 Ravaioli, S; Bravaccini, S; Tumedei, Mm; Pironi, F; Candoli, P; Puccetti, M
Progress with palbociclib in breast cancer: latest evidence and clinical considerations
2017-01-01 Rocca, A; Schirone, A; Maltoni, R; Bravaccini, S; Cecconetto, L; Farolfi, A; Bronte, G; Andreis, D
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer
2017-01-01 Maltoni, R; Casadio, V; Ravaioli, S; Foca, F; Tumedei, Mm; Salvi, S; Martignano, F; Calistri, D; Rocca, A; Schirone, A; Amadori, D; Bravaccini, S
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?
2018-01-01 Bronte, G; Bravaccini, S; Ravaioli, S; Puccetti, M; Scarpi, E; Andreis, D; Tumedei, Mm; Sarti, S; Cecconetto, L; Pietri, E; De Simone, V; Maltoni, R; Bonafe, M; Amadori, D; Rocca, A
Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer?
2018-01-01 Puccetti, M; Ravaioli, S; Tumedei, Mm; Bucchi, E; Malmesi, M; Medri, L; Bravaccini, S
Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence
2018-01-01 Rocca, A; Maltoni, R; Bravaccini, S; Donati, C; Andreis, D
Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancer
2018-01-01 Bronte, G; Bravaccini, S; Bronte, E; Burgio, Ma; Rolfo, C; Delmonte, A; Crino, L
PSMA expression: A potential ally for the pathologist in prostate cancer diagnosis
2018-01-01 Bravaccini, S.; Puccetti, M.; Bocchini, M.; Ravaioli, S.; Celli, M.; Scarpi, E.; De Giorgi, U.; Tumedei, M. M.; Raulli, G.; Cardinale, L.; Paganelli, G.
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
2018-01-01 Bronte, Giuseppe; Rocca, Andrea; Ravaioli, Sara; Puccetti, Maurizio; Tumedei Maria, Maddalena; Scarpi, Emanuela; Andreis, Daniele; Maltoni, Roberta; Sarti, Samanta; Cecconetto, Lorenzo; Pietri, Elisabetta; De Simone, Valeria; Asioli, Silvia; Amadori, Dino; Bravaccini, S
Petals and Thorns in Programmed Death-Ligand 1 Testing: Is All Non-Small Cell Lung Cancer Diagnostic Material Suitable?
2018-01-01 Bravaccini, S; Bronte, G
Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR)
2018-01-01 Chiadini, E; Canale, M; Delmonte, A; Dazzi, C; Casanova, C; Capelli, L; Mariotti, M; Papi, M; Gamboni, A; Puccetti, M; Bravaccini, S; Dubini, A; Calistri, D; Crino, L; Ulivi, P
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?
2018-01-01 Bravaccini, S; Ravaioli, S; Amadori, D; Scarpi, E; Puccetti, M; Rocca, A; Tumedei, Mm; Masalu, N; Kahima, J; Pangan, A; Faustine, L; Farolfi, A; Maltoni, R; Bonafe, M; Serra, P; Bronte, G
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer?
2018-01-01 Bravaccini, S; Rocca, A; Bronte, G
What to look for in cell-free DNA from breast cancer patients
2018-01-01 Bronte, G; Ravaioli, S; Bravaccini, S
Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer
2019-01-01 D'Arcangelo, M; D'Incecco, A; Ligorio, C; Damiani, S; Puccetti, M; Bravaccini, S; Terracciano, L; Bennati, C; Minuti, G; Vecchiarelli, S; Landi, L; Milesi, M; Meroni, A; Ravaioli, S; Tumedei, Mm; Incarbone, M; Cappuzzo, F.
Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma
2019-01-01 Dhieb, D; Belguith, I; Capelli, L; Chiadini, E; Canale, M; Bravaccini, S; Yangui, I; Boudawara, O; Jlidi, R; Boudawara, T; Calistri, D; Keskes, La; Ulivi, P
Explaining the aggressiveness of breast cancer in sub-Saharan African patients
2019-01-01 Bravaccini, S; Bucchi, L; Puccetti, M; Ravaioli, S; Tumedei, Mm; Serra, P; Masini, C; Kahima, J; Masalu, N; Amadori, D
What impacts the cost-effectiveness of PD-L1 testing in non-small cell lung cancer?
2019-01-01 Bravaccini, S
Epithelial-to-mesenchymal transition and EGFR status in NSCLC: the role of vimentin expression
2019-01-01 Bronte, G; Puccetti, M; Crino, L; Bravaccini, S
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
2019-01-01 Bravaccini, S; Maltoni, R
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology | 1-gen-2017 | Ravaioli, S; Bravaccini, S; Tumedei, Mm; Pironi, F; Candoli, P; Puccetti, M | |
| Progress with palbociclib in breast cancer: latest evidence and clinical considerations | 1-gen-2017 | Rocca, A; Schirone, A; Maltoni, R; Bravaccini, S; Cecconetto, L; Farolfi, A; Bronte, G; Andreis, D | |
| Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer | 1-gen-2017 | Maltoni, R; Casadio, V; Ravaioli, S; Foca, F; Tumedei, Mm; Salvi, S; Martignano, F; Calistri, D; Rocca, A; Schirone, A; Amadori, D; Bravaccini, S | |
| Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases? | 1-gen-2018 | Bronte, G; Bravaccini, S; Ravaioli, S; Puccetti, M; Scarpi, E; Andreis, D; Tumedei, Mm; Sarti, S; Cecconetto, L; Pietri, E; De Simone, V; Maltoni, R; Bonafe, M; Amadori, D; Rocca, A | |
| Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer? | 1-gen-2018 | Puccetti, M; Ravaioli, S; Tumedei, Mm; Bucchi, E; Malmesi, M; Medri, L; Bravaccini, S | |
| Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence | 1-gen-2018 | Rocca, A; Maltoni, R; Bravaccini, S; Donati, C; Andreis, D | |
| Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancer | 1-gen-2018 | Bronte, G; Bravaccini, S; Bronte, E; Burgio, Ma; Rolfo, C; Delmonte, A; Crino, L | |
| PSMA expression: A potential ally for the pathologist in prostate cancer diagnosis | 1-gen-2018 | Bravaccini, S.; Puccetti, M.; Bocchini, M.; Ravaioli, S.; Celli, M.; Scarpi, E.; De Giorgi, U.; Tumedei, M. M.; Raulli, G.; Cardinale, L.; Paganelli, G. | |
| Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy? | 1-gen-2018 | Bronte, Giuseppe; Rocca, Andrea; Ravaioli, Sara; Puccetti, Maurizio; Tumedei Maria, Maddalena; Scarpi, Emanuela; Andreis, Daniele; Maltoni, Roberta; Sarti, Samanta; Cecconetto, Lorenzo; Pietri, Elisabetta; De Simone, Valeria; Asioli, Silvia; Amadori, Dino; Bravaccini, S | |
| Petals and Thorns in Programmed Death-Ligand 1 Testing: Is All Non-Small Cell Lung Cancer Diagnostic Material Suitable? | 1-gen-2018 | Bravaccini, S; Bronte, G | |
| Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR) | 1-gen-2018 | Chiadini, E; Canale, M; Delmonte, A; Dazzi, C; Casanova, C; Capelli, L; Mariotti, M; Papi, M; Gamboni, A; Puccetti, M; Bravaccini, S; Dubini, A; Calistri, D; Crino, L; Ulivi, P | |
| Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population? | 1-gen-2018 | Bravaccini, S; Ravaioli, S; Amadori, D; Scarpi, E; Puccetti, M; Rocca, A; Tumedei, Mm; Masalu, N; Kahima, J; Pangan, A; Faustine, L; Farolfi, A; Maltoni, R; Bonafe, M; Serra, P; Bronte, G | |
| Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer? | 1-gen-2018 | Bravaccini, S; Rocca, A; Bronte, G | |
| What to look for in cell-free DNA from breast cancer patients | 1-gen-2018 | Bronte, G; Ravaioli, S; Bravaccini, S | |
| Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer | 1-gen-2019 | D'Arcangelo, M; D'Incecco, A; Ligorio, C; Damiani, S; Puccetti, M; Bravaccini, S; Terracciano, L; Bennati, C; Minuti, G; Vecchiarelli, S; Landi, L; Milesi, M; Meroni, A; Ravaioli, S; Tumedei, Mm; Incarbone, M; Cappuzzo, F. | |
| Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma | 1-gen-2019 | Dhieb, D; Belguith, I; Capelli, L; Chiadini, E; Canale, M; Bravaccini, S; Yangui, I; Boudawara, O; Jlidi, R; Boudawara, T; Calistri, D; Keskes, La; Ulivi, P | |
| Explaining the aggressiveness of breast cancer in sub-Saharan African patients | 1-gen-2019 | Bravaccini, S; Bucchi, L; Puccetti, M; Ravaioli, S; Tumedei, Mm; Serra, P; Masini, C; Kahima, J; Masalu, N; Amadori, D | |
| What impacts the cost-effectiveness of PD-L1 testing in non-small cell lung cancer? | 1-gen-2019 | Bravaccini, S | |
| Epithelial-to-mesenchymal transition and EGFR status in NSCLC: the role of vimentin expression | 1-gen-2019 | Bronte, G; Puccetti, M; Crino, L; Bravaccini, S | |
| CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough? | 1-gen-2019 | Bravaccini, S; Maltoni, R |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile